Cargando…
Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor()()
BACKGROUND: Although the contrast-enhancing (CE) lesion on T(1)-weighted MR images is widely used as a surrogate for glioblastoma (GBM), there are also non-enhancing regions of infiltrative tumor within the T(2)-weighted lesion, which elude radiologic detection. Because non-enhancing GBM (Enh−) chal...
Autores principales: | Autry, Adam, Phillips, Joanna J., Maleschlijski, Stojan, Roy, Ritu, Molinaro, Annette M., Chang, Susan M., Cha, Soonmee, Lupo, Janine M., Nelson, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612804/ https://www.ncbi.nlm.nih.gov/pubmed/28942218 http://dx.doi.org/10.1016/j.tranon.2017.08.009 |
Ejemplares similares
-
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab
por: Nelson, Sarah J., et al.
Publicado: (2016) -
Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials()
por: Wen, Qiuting, et al.
Publicado: (2015) -
Repeatability of Contrast-Enhanced Ultrasound to Determine Renal Cortical Perfusion
por: Almushayt, Shatha J., et al.
Publicado: (2022) -
Contrast-enhanced ultrasound perfusion imaging of organs
por: Jung, Ernst-Michael, et al.
Publicado: (2021) -
GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity
por: Lindberg, Olle R., et al.
Publicado: (2016)